Forsta AP Fonden raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,944 shares of the healthcare conglomerate’s stock after buying an additional 3,700 shares during the period. Forsta AP Fonden’s holdings in UnitedHealth Group were worth $6,108,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Patriot Financial Group Insurance Agency LLC raised its position in UnitedHealth Group by 1,722.9% in the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after buying an additional 603 shares during the period. Cribstone Capital Management LLC raised its position in UnitedHealth Group by 22.6% in the first quarter. Cribstone Capital Management LLC now owns 678 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 125 shares during the period. Kings Point Capital Management raised its position in UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after buying an additional 150 shares during the period. Founders Capital Management acquired a new position in UnitedHealth Group during the first quarter valued at approximately $135,000. Finally, Parkside Financial Bank & Trust raised its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares during the period. Institutional investors and hedge funds own 86.21% of the company’s stock.

UnitedHealth Group Incorporated (NYSE UNH) traded up 0.19% on Monday, reaching $193.39. 1,033,687 shares of the company’s stock were exchanged. The stock has a market cap of $186.98 billion, a price-to-earnings ratio of 23.23 and a beta of 0.64. UnitedHealth Group Incorporated has a one year low of $132.39 and a one year high of $196.04. The firm has a 50 day moving average of $189.36 and a 200-day moving average of $174.75.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. The company had revenue of $50.05 billion for the quarter, compared to analyst estimates of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The business’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.96 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Forsta AP Fonden Boosts Position in UnitedHealth Group Incorporated (UNH)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/14/forsta-ap-fonden-boosts-position-in-unitedhealth-group-incorporated-unh.html.

Several research firms have commented on UNH. UBS AG reiterated a “buy” rating and set a $194.00 price objective (up previously from $193.00) on shares of UnitedHealth Group in a research report on Saturday, April 22nd. Cowen and Company reiterated an “outperform” rating and set a $220.00 price objective (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a research report on Friday, June 9th. Citigroup Inc. increased their price objective on shares of UnitedHealth Group from $195.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Finally, BidaskClub upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, June 9th. One equities research analyst has rated the stock with a hold rating and twenty-four have given a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $202.20.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,540 shares of the business’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now directly owns 60,516 shares in the company, valued at $10,816,629.84. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction dated Thursday, August 3rd. The stock was sold at an average price of $193.98, for a total transaction of $969,900.00. Following the sale, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The disclosure for this sale can be found here. Insiders have sold 15,540 shares of company stock worth $2,873,320 over the last quarter. Insiders own 0.89% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.